Top 5 Warren Buffett Stocks To Invest In 2014

Earnings season is in full swing, and a full third of companies on the Dow Jones Industrial Average (DJINDICES: ^DJI  ) is set to report last quarter’s data this week. From industrial giants such as Caterpillar (NYSE: CAT  ) to Big Oil icons like ExxonMobil (NYSE: XOM  ) and Chevron (NYSE: CVX  ) , seemingly every sector of the blue-chip index is on pace to capture investors’ attention in the next few days. Let’s take a look at what you should be watching out for as 10 of America’s most prominent stocks face their biggest test so far of 2013.

Five days of earnings
Caterpillar’s set to start a busy week for blue-chip investors when it reports earnings data on Monday. The industrial stock’s been hammered in 2013, losing nearly 14% year to date as China’s economic slowdown has hampered the company’s growth. Analysts are expecting a big hit to the company’s financials, projecting a 39% dip in earnings per share over a year ago, with a year-over-year drop in revenue of more than 13%. The company’s sales have dropped in recent months, and it could be a while before this stock makes a recovery. Don’t expect a miracle from this earnings season.

Top 5 Warren Buffett Stocks To Invest In 2014: Calgon Carbon Corp (CCC)

Calgon Carbon Corporation is a provider of products, services, and solutions for purifying water and air. The Company operates in three reportable segments: Activated Carbon and Service, Equipment, and Consumer. The Activated Carbon and Service segment manufactures granular and powdered activated carbon for use in applications to primarily remove organic compounds from water, air and other liquids and gases. The service aspect of the segment consists of reactivation and the leasing, monitoring and maintenance of carbon adsorption equipment. The Equipment segment provides solutions to customers’ air and water purification problems through the design, fabrication, installation, and sale of equipment systems that utilize a combination of the Company’s enabling technologies: carbon adsorption, ultraviolet light (UV), Ballast Water Treatment (BWT), and advanced ion exchange separation (ISEP). The Consumer segment primarily consists of the manufacture and sale of carbon clot h. On March 31, 2011 the Company completed the acquisition of Calgon Carbon Japan KK (CCJ).

Activated Carbon and Service

The sale of activated carbon is the principle component of the Activated Carbon and Service business segment. Activated carbon is a porous material that removes organic compounds from liquids and gases by a process known as adsorption. In adsorption, unwanted organic molecules contained in a liquid or gas are attracted and bound to the surface of the pores of the activated carbon as the liquid or gas is passed through. The primary raw material used in the production of the Company’s activated carbons is bituminous coal which is crushed, sized and then processed in low temperature kilns followed by high temperature furnaces. The Company also markets activated carbons from other raw materials, including coconut shell and wood. The Company produces and sells a range of activated, impregnated or acid washed carbons in granular, powd ered or pellet form. Granular activated carbon (GAC) particl! es are irregular in shape and generally used in fixed filter beds for continuous flow purification processes.

Another component of the Activated Carbon and Service business segment are the optional services associated with supplying the Company’s products and systems required for purification, separation, concentration, taste and odor control. The Company offers a variety of treatment services at customer facilities, including carbon supply, equipment leasing, installation and demobilization, transportation and spent carbon reactivation. Other services include feasibility testing, process design, performance monitoring and maintenance of Company-owned equipment. The central component of the Company’s service business is reactivation of spent carbon and re-supply. The Company provides reactivation/recycling services in packages ranging from a 55 gallon drum to truckload quantities.

Equipment

Along with providing activated carbon pro ducts, the Company has developed a portfolio of standardized, pre-engineered, adsorption systems capable of treating liquid flows from 1 gallons per minute to 1,400 gallons per minute, which can be delivered and installed at treatment sites. These self-contained adsorption systems are used for vapor phase applications, such as volatile organic compound (VOC) control, air stripper off-gases, and landfill gas emissions. Liquid phase equipment systems are used for applications of potable water, process purification, wastewater treatment, groundwater remediation and de-chlorination. The Company produces a range of odor control equipment, which typically utilizes catalytic activated carbon to control odors at municipal wastewater treatment facilities and pumping stations. The Company’s variety of equipment systems treats the odors that emanate from municipal wastewater treatment facilities and the sewage collection systems that bring the waste to the treatment plant.

The ISEP (Ionic Separator) continuous ion exchange units ! are used ! for the purification and recovery of many products in the food, pharmaceutical, and biotechnology industries. The ISEP Continuous Separator units perform ion exchange separations using countercurrent processing. The ISEP and CSEP (chromatographic separator) systems are used at over 300 installations worldwide in more than 40 applications in industrial settings, as well as in environmental applications, including perchlorate and nitrate removal from drinking water. The Hyde GUARDIAN System was developed as a chemical-free, International Maritime Organization (IMO) type approved, ballast water management solution. The system is designed to meet the needs of ship owners to install treatment system.

Consumer

The primary product offered in the Consumer segment is carbon cloth. Carbon cloth, which is activated carbon in cloth form, is manufactured in the United Kingdom and sold to the medical, military, and specialty markets. Zorflex Activated Carbon Clo th can be used in numerous additional applications, including sensor protection; filters for ostomy bags; wound dressings; conservation of artifacts, and respiratory masks.

The Company competes with Norit, N.V., Mead/Westvaco Corporation, Siemens Water Technologies, Trojan Technologies, Inc., Xylem, Wedeco Ideal Horizons, Panasia, Alfa Lavel Tumba AB, Hyde Marine, Inc. and Wartsila.

Advisors’ Opinion:

  • [By Inyoung Hwang]

    Computacenter Plc (CCC) slipped 4.5 percent to 543 pence, its biggest drop since June. UBS AG lowered the technology-services provider to neutral from buy, citing its valuation. The shares have climbed to 13.18 times estimated earnings from 11.81 times at the end of last year, according to data compiled by Bloomberg.

Top 5 Warren Buffett Stocks To Invest In 2014: Netflix Inc.(NFLX)

Netflix, Inc. provides Internet subscription services for TV shows and movies in the United States and internationally. The company offers its subscribers to watch unlimited TV shows and movies streamed over the Internet to their TVs, computers, and mobile devices. It also provides standard definition DVDs and Blu-ray discs to its subscribers. The company was founded in 1997 and is headquartered in Los Gatos, California.

Advisors’ Opinion:

  • [By Ben Levisohn]

    Investors in what had been some of the market’s hottest stocks must surely feel as if they’ve been hit by the wrath of a vengeful deity this week. Sure, the S&P 500 fell just 0.5% this week after rallying 0.5% to 1,857.62 on Friday, but that was despite big drops in  Netflix (NFLX), which plunged 12% this week, Facebook (FB) which fell 11%, E*Trade Financial (ETFC), which declined 9.1%, and Biogen Idec (BIIB), which dropped 7.7%.

  • [By Ben Levisohn]

    Stocks fell today despite the lack of anything significant that would drive down the prices of Netflix (NFLX), Alexion Pharmaceuticals (ALXN) and Facebook (FB), among other high fliers.

Top 5 Warren Buffett Stocks To Invest In 2014: Sibling Group Holdings Inc (SIBE)

Sibling Group Holdings Inc., incorporated on December 28, 1988, is a development-stage company. During the year ended December 31, 2012, the Company was not engaged in any business operations.

The Company has entered into an Agreement of Acquisition and Plan of Reorganization with Sibling Entertainment Group, Inc. (Sibling) to acquire Sibling’s four wholly owned subsidiaries: Sibling Theatricals, Inc., Sibling Pictures, Inc., Sibling Music Corp., and Sibling Properties, Inc. and their subsidiaries, including Dick Foster Productions, Inc., Adrenaline MMA, Inc., Hats Holdings, Inc. amongst others. The Company was organized primarily for the purpose of importing fruits and vegetables from Latin America.

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap holding companies Sibling Group Holdings Inc (OTCMKTS: SIBE), Tranzbyte Corp (OTCMKTS: ERBB) and Readen Holding Corp (OTCMKTS: RHCO) are in the business of holding or acquiring other companies. They have also been getting some attention lately in various investment newsletters and not necessarily because of acquisitions or other news but rather because of a few recent paid promotions. With that in mind, here is a quick look and a reality check about all three:

    Sibling Group Holdings Inc (OTCMKTS: SIBE) Has Been Quiet Lately

    Small cap Sibling Group Holdings intends to acquire, on a global basis, advanced technology and education management operations in order to enhance and accelerate the delivery of 21st century learning. On Friday, Sibling Group Holdings closed at $0.05 for a market cap of $39,342 plus SIBE is down 96.7% over the past year and down 80% over the past five years according to Google Finance.

Top 5 Warren Buffett Stocks To Invest In 2014: M.D.C. Holdings Inc. (MDC)

M.D.C. Holdings, Inc., through its subsidiaries, engages in homebuilding and financial services businesses in the United States. Its homebuilding business activities include the purchase of finished lots or development of lots for the construction and sale of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name. The company’s financial services business activities comprise the origination of mortgage loans primarily for homebuyers; provision of third-party insurance products to homebuyers; and title agency services to homebuyers in Colorado, Florida, Maryland, Nevada, and Virginia. It also provides insurance coverage on homes sold and for work performed in completed subdivisions; and re-insures the claims. M.D.C. Holdings, Inc. was founded in 1972 and is based in Denver, Colorado.

Advisors’ Opinion:

  • [By Charley Blaine]

    Among the losers: AIG, down 6.9 percent; gold-miner Newmont Mining (NYSE: NEM), down 4.7 percent; and homebuilder M.D.C. Holdings (NYSE: MDC), down 1.37 percent.

  • [By Rich Smith]

    Upping MDC Holdings to buy
    Before moving on to the bad news, let’s start with some good. Investment banker KeyBanc Capital Markets thinks that in view of the broad strength in housing stocks lately, it’s time to revisit the sector, take some winnings off the table, and move a bit of that money into stocks with perhaps a bit more potential to keep growing. It’s choice today: MDC Holdings (NYSE: MDC  ) .

  • [By The Oxen Group]

    MDC Holdings (MDC) through its subsidiary Richmond American Homes builds new single family homes in various regions of the country and provides mortgage services as well. We initiate a BUY recommendation as we believe company shares have the potential to appreciate by 50% in the next 12 months. MDC is entering the upscale housing market that, if profitable, could potentially lead the way to further development in this direction. The company could also see a revenue boost and better market share due to implementations of new standard energy features that separates itself from competition.

Top 5 Warren Buffett Stocks To Invest In 2014: Anacor Pharmaceuticals Inc. (ANAC)

Anacor Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. The company’s lead product candidates include tavaborole, an antifungal product candidate that is in Phase III clinical development for the treatment of onychomycosis; and AN2728, an anti-inflammatory product candidate, which completed Phase II clinical trials for the treatment of atopic dermatitis and psoriasis. It also develops AN5568, a Phase I human clinical trial product targeting human African trypanosomiasis; and other compounds to treat animal health indications. The company’s clinical pipeline also includes AN2718, a topical antifungal product candidate, which is in Phase I clinical trials for the treatment of onychomycosis and fungal infections of the skin; AN2898, a topical anti-inflammatory product candidate that completed the Phase IIa clinical trials for the treatment of atopic dermatitis and psoriasis; and AN3365, an antibiotic for the treatment of infections caused by Gram-negative bacteria. It has research, development, and collaboration agreements with GlaxoSmithKline LLC, Eli Lilly and Company, Medicis Pharmaceutical Corporation, and Medicines for Malaria Ventures. The company was formerly known as AnaMax, Inc. and changed its name to Anacor Pharmaceuticals, Inc. in October 2002. Anacor Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Palo Alto, California.

Advisors’ Opinion:

  • [By John Kell and Lauren Pollock var popups = dojo.query(“.socialByline .popC”); ]

    Anacor Pharmaceuticals Inc.(ANAC) swung to a profit in the fourth quarter, driven by gains from a litigation settlement and a rise in revenue. The company’s revenue beat market expectations. Shares rose 6.4% to $21.45 in light premarket trading.

  • [By Lauren Pollock]

    Valeant Pharmaceuticals International Inc.(VRX.T) will pay $142.5 million to Anacor Pharmaceuticals Inc.(ANAC) to resolve all outstanding disputes between the two companies. The settlement resolves litigation over alleged breaches of contract involving Valeant units Dow Pharmaceuticals Sciences Inc. and Medicis Pharmaceutical Corp.

  • [By Eric Volkman]

    Anacor Pharmaceuticals (NASDAQ: ANAC  ) is tapping the markets for a fresh infusion of capital. The company has put a price tag of $6.39 per share on its current underwritten public stock issue, in which it is aiming to unload nearly 3.13 million common shares. Additionally, the company’s underwriters have been granted a 30-day purchase option for up to an additional 15% of the number of issued shares, in order to cover over-allotments.

  • [By Grace L. Williams]

    Honorable mentions go out to Coronado Biosciences (CNDO), after its CEO Harlan Weisman and Jay Lobell, a longtime director, joined forces and bought 20,000 shares for $152,100; and to Anacor Pharmaceuticals (ANAC) after CFO Geoffrey Parker bought 33,000 shares for $224,300. InsiderScore noted that Parker’s purchase was his largest to date and called it a “compelling positive event.”